Medi-Tech Insights Research Reports

The global drug discovery software market (such as ligand-based design, structure-based design, LIMS, ELN) is driven by the increasing R&D spend and pipeline, expanding scope and scale, increasing stringency of testing and regulations, growing number and size of biotechs, need for increasing cost efficiencies and reducing time to market, and move towards web/cloud-based software. Global Drug Discovery Software Market – Niche but Fast-Growing Market The worldwide drug discovery software market is niche and growing rapidly, driven by the rising pressure on the pharma and biotech companies to cut costs in the research and preclinical stage of drug development, reduce timelines and improve transparency through deep learning software tools. “ Large players present in this segment are trying to consolidate the market by becoming a one stop shop. Moreover, companies are also considering to combine their solutions with bioinformatics and LIMS tools to have a competitive edge .” - Exe

Women’s Health is a branch of medicine that focuses on the prevention and diagnosis of diseases that affect a woman’s physical and emotional well-being. It encompasses a broad variety of treatments, drugs, and surgical products for diseases related to women. Emerging Opportunities in Women’s Health Market The rising prevalence of infectious and chronic diseases amongst a large group of the female population is a key factor driving the women’s health market. Recent advances in genomics, tissue engineering, artificial intelligence, and cell and gene therapy have synergized a new wave of healthcare innovations that can be applied to create products and solutions specific to women's conditions. For example, researchers are studying transcriptomics (the study of RNA molecules in a cell) for treating elusive conditions such as preeclampsia or preterm birth. Genomics is another research area that can help researchers in realizing the potential of personalized medicine. Th ere has b

In recent years, the healthcare industry has witnessed the foray of several providers that offer software for behavioral and mental health practices: EHR, teletherapy, scheduling, client engagement, billing, and digital therapeutics to prevent, manage and treat medical disorders. Rising Demand for Digital Behavioral/Mental Health Market Solutions With lockdowns implemented, social distancing mandated, and widespread apprehension – Covid-19 placed a dramatic burden on managed healthcare and especially on neurological and psychiatric disease care. The ubiquity of personal digital devices—smartphones, fitness trackers, tablets, and the launch of digital solutions ensured that the digital mental health tools were accessed more frequently and by a wider demographic of patients. Benefits such as therapeutic approaches to support positive behavioral change on a large scale, anywhere, anytime accessibility, on-demand help without waiting lines, convenience, and ease of use were the key f

Robust CGT pipeline with growing number of product approvals, strong support from large pharma and biotech, and consistent investor enthusiasm (~$20 bn raised in 2020) is set to boost the demand for CGT services. A growing pipeline of therapies are nearing regulatory decisions. Out of 1,220 ongoing clinical trials in 2020, 152 were in Phase 3 — FDA and EMA predict approval of 10-20 cell and gene therapies each year by 2025. Rising Demand for Full-service/One-stop-shop CDMOs Full-service CDMOs that can assist with both development and manufacturing are in utmost demand. Much of the CGT development as of late has been from smaller biotech companies or research universities who rely on CDMOs from preclinical development through packaging. “There is growing demand for Cell and Gene Therapy CTDMOs who can offer integrated development, manufacturing, and testing services. For CGT companies, outsourcing manufacturing and testing operations to a capable CTDMO can reduce development timel

Cost savings, scalability, technology know-how, and risk mitigation offered by IVD contract manufacturers drive OEM's decision to outsource to IVD CDMOs. Increasing Preference for Point-of-Care (POC) Testing Services Fuels the growth of IVD Contract Manufacturing Services Market In an endeavor to cut result time and help patients make better-informed decisions about their health, there is considerable demand for IVD testing to move closer to the patient i.e. point-of-care (POC) diagnostics whether in the hospital, clinic, physician's office, or home. Manufacturing of specific PoC devices presents manufacturers (OEMs) with a variety of design and manufacturing challenges. For instance, the ability to process high-precision components that involve reagents and fluids are the most relevant capabilities sought by OEMs, which are accomplished by specialized IVD CDMOs. IVD Diagnostic Kits Demand Triggered by Covid-19 Pandemic bolsters the IVD Contract Manufacturing Services M

Medical image analysis software uses deep learning algorithms to read and evaluate images. Increasing Volume of Medical Images Coupled with Shortage of Radiologists Medical images make up ~90% of the data in healthcare and >95% of it goes unanalyzed or unused. The number of images generated globally increases every year and this trend is likely to continue, as growing number of people will gain access to better medical care. Growing volume of images puts pressure on radiologists. This issue further intensifies with the shortage of trained radiologists across the globe. This in turn drives the adoption of medical image analysis software which helps increase the speed and accuracy of analysis thereby reducing report turnaround time. However, flawed, incomplete or poor-quality images can pose challenge to efficiently make use of this software. Technological Advancements in Medical Image Analysis Software Market While medical imaging analysis software can definitely reduce radio

Flow Cytometry is a technique used to detect and measure physical and chemical characteristics of a population of cells or particles usually suspended in a fluid using a laser beam. Most common types of flow cytometry-based proliferation assays are cell-based and bead-based  assays. Increasing Adoption of Flow Cytometry Market in Stem Cell Research Flow cytometry and cell sorting are critical tools in stem cell research. Recent advances in flow cytometric hardware, reagents, software platforms and algorithms have synergized to permit the stem cell biologist in better identifying and isolating rare cells based on their immunofluorescence and light scattering characteristics. By multiple fluorescent-labeled antibodies, researchers can obtain robust data and population-based statistics on differentiating stem cell cultures. The growing market penetration in stem cell research, adoption of recombinant DNA technology for antibody production, and evolution of tandem flow cytometry techno

Non-invasive prenatal testing (NIPT), is a method of determining the risk of whether the fetus of the mother will be born with certain genetic abnormalities. NIPT is a safe and highly effective way of screening for conditions such as Down syndrome, Edwards syndrome , Patau syndrome, monosomy X, and Turner syndrome . Currently, there is two types of NIPT methods that are commercially available, massive parallel sequencing (MPS) technology and the single-nucleotide polymorphism (SNP) based method. Rapid Shift towards Cell-Free DNA screening The Discovery of cell-free DNA (cfDNA)-based NIPT has created a rapid shift in the paradigm of aneuploidy screening during pregnancy. It’s a simple blood test that can be performed during pregnancy. Clinical validation studies suggest that NIPT is more accurate than combined first-trimester screening (CFTS), with very high sensitivity (99.3%) and specificity (99.9%) for trisomy 21(Down syndrome). NIPT is also safer than other invasive diagnostic

Nanopore Sequencing, a fourth-generation sequencing technology, in which single strands of DNA or RNA are passed through tiny protein channel called as nanopore. These nanopores are embedded in an electrically resistant membrane that causes changes in the ion current, determining the sequence and modifications of bases. Advantages of Nanopore Sequencing Technology fuels Its Demand Over the years, there has been a significant increase in the adoption of nanopore sequencing for research as well as clinical applications because of significant advantages of nanopores such as label-free & ultralong reads and high throughput. Some of the key benefits that are driving its demand are: Long-read sequencing: The ability to produce ultra-long reads of over 2 Mb is a major advantage of nanopore sequencing. Longer read lengths are more likely to cover full regions of repeated sequence and structural variation, allowing for a more comprehensive understanding of genetic variants and the recon